Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.

Vitturi G, Piccoli L, Spini A, Pellegrini G, L'Abbate L, Bellitto C, Ingrasciotta Y, Leoni O, Mazzone A, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Allotta A, Pollina SA, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Tuccori M, Gini R, Trama U, Bernardi FF, Mayer F, Spila Alegiani S, Massari M, Adami S, Scroccaro G, Trifirò G

Open source

DOI
10.1007/s40290-026-00629-7
Published
2026 Aug 18
Container
Pharmaceutical medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00629-7,
  title = {Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.},
  author = {Vitturi G and Piccoli L and Spini A and Pellegrini G and L'Abbate L and Bellitto C and Ingrasciotta Y and Leoni O and Mazzone A and Ancona D and Stella P and Cavazzana A and Scapin A and Lopes S and Belleudi V and Ledda S and Carta P and Rossi P and Ejlli L and Sapigni E and Puccini A and Scarpelli RF and De Sarro G and Allotta A and Pollina SA and Da Cas R and Bucaneve G and Mangano AMP and Balducci F and Sorrentino C and Senesi I and Tuccori M and Gini R and Trama U and Bernardi FF and Mayer F and Spila Alegiani S and Massari M and Adami S and Scroccaro G and Trifirò G},
  year = {2026},
  journal = {Pharmaceutical medicine},
  doi = {10.1007/s40290-026-00629-7},
  url = {https://doi.org/10.1007/s40290-026-00629-7}
}

RIS

TY  - JOUR
TI  - Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.
AU  - Vitturi G
AU  - Piccoli L
AU  - Spini A
AU  - Pellegrini G
AU  - L'Abbate L
AU  - Bellitto C
AU  - Ingrasciotta Y
AU  - Leoni O
AU  - Mazzone A
AU  - Ancona D
AU  - Stella P
AU  - Cavazzana A
AU  - Scapin A
AU  - Lopes S
AU  - Belleudi V
AU  - Ledda S
AU  - Carta P
AU  - Rossi P
AU  - Ejlli L
AU  - Sapigni E
AU  - Puccini A
AU  - Scarpelli RF
AU  - De Sarro G
AU  - Allotta A
AU  - Pollina SA
AU  - Da Cas R
AU  - Bucaneve G
AU  - Mangano AMP
AU  - Balducci F
AU  - Sorrentino C
AU  - Senesi I
AU  - Tuccori M
AU  - Gini R
AU  - Trama U
AU  - Bernardi FF
AU  - Mayer F
AU  - Spila Alegiani S
AU  - Massari M
AU  - Adami S
AU  - Scroccaro G
AU  - Trifirò G
PY  - 2026
JO  - Pharmaceutical medicine
DO  - 10.1007/s40290-026-00629-7
UR  - https://doi.org/10.1007/s40290-026-00629-7
ER  - 

APA

G, V., L, P., A, S., G, P., L, L., C, B., Y, I., O, L., A, M., D, A., P, S., A, C., A, S., S, L., V, B., S, L., P, C., P, R., L, E., E, S., A, P., RF, S., G, D. S., A, A., SA, P., R, D. C., G, B., AMP, M., F, B., C, S., I, S., M, T., R, G., U, T., FF, B., F, M., S, S. A., M, M., S, A., G, S., & G, T. (2026). Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.. Pharmaceutical medicine. https://doi.org/10.1007/s40290-026-00629-7

Source records